Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108816290A introduces a mixed-ligand copper catalyst for efficient C-N bond construction, offering cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102277322A details a green enzymatic route for IDA production, offering lower costs and reduced waste compared to traditional chemical hydrolysis methods.
Novel ferrocene-derived iridium catalyst enables high-efficiency chiral amine synthesis with reduced processing costs for reliable agrochemical intermediate supply chains.
Patent CN105777462A reveals a novel Pd-Cu catalytic route for phenanthrene intermediates. Achieve high yields and reduced manufacturing costs with scalable technology.
Patent CN106478521A reveals novel diarylpyrimidine synthesis with enhanced flexibility. Offers supply chain stability and cost reduction for pharmaceutical manufacturing.
Patent CN112812060A reveals metal-free arylation. Offers green synthesis for high-purity pharmaceutical intermediates with simplified supply chains.
Patent CN113481175B discloses OYE2p mutants for stereoselective citral reduction. Discover cost-effective biocatalysis solutions for flavor and fragrance intermediates.
Novel chiral Lewis acid process for high-purity diltiazem intermediates. Reduces steps and eliminates expensive reagents for scalable pharmaceutical manufacturing.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Advanced synthesis of oxadiazole hydrazides for fungicidal applications. Cost-effective route with high yield and scalable production capabilities for global agrochemical supply chains.
Patent CN1812990A details a novel Pd/C catalyzed route for famciclovir, achieving superior purity by minimizing hydrolysis impurities through optimized solvent systems.
Patent CN1530171A discloses a robust heterogeneous catalyst system for producing high-ee hydroxy esters, enabling significant cost reduction in chiral synthesis manufacturing.
Patent CN1538950A details a mild transfer hydrogenation method for amine synthesis using Ru/Rh catalysts, offering cost reduction in API manufacturing and high optical purity.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced synthesis of 3-dehydroshikimic esters via IBX oxidation. A scalable, high-yield route for pharmaceutical intermediates offering significant cost and supply chain advantages.
Patent CN85103245A details novel rhodium-diphosphine complexes enabling high-yield asymmetric hydrogenation for pharmaceutical intermediates with reduced catalyst loading.
Patent CN1237040C reveals a high-yield synthesis method for ethylene glycol diaryl ether using neighboring group participation, offering significant cost and purity advantages for industrial supply chains.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN101039894A reveals stabilized Rh-catalyzed asymmetric hydrogenation for high-purity citronellal production, offering significant cost reduction in flavor manufacturing.
Novel ionic liquid method for 16α-hydroxyprednisolone. Reduces waste and cost. Reliable pharmaceutical intermediates supplier for global supply chains.